Clinical Study
Clinical Characteristics and Risk Factors of Recurrent Mooren’s Ulcer
Table 3
Clinical treatment of affected eyes.
| | Variables | Total () | Recurrent group () | Nonrecurrent group () | Fisher value | |
| | Treatment | | | | 4.889 | 0.420 | | Medicine | 14 (14.0%) | 3 (6.7%) | 11 (20.0%) | | | | Surgery methods | 86 (86.0%) | 42 (93.3%) | 44 (80.0%) | | | Partial LKP | 48 (48.0%) | 24 (53.3%) | 24 (43.7%) | | | | Total LKP | 21 (21.0%) | 10 (22.2%) | 11 (20.0%) | | AMT | 13 (13.0%) | 7 (15.6%) | 6 (10.9%) | | CF | 4 (4.0%) | 1 (2.2%) | 3 (5.4%) |
|
|
LKP: lamellar keratoplasty; AMT: amniotic membrane transplantation; CF: conjunctival flap.
|
